Invention Grant
- Patent Title: GLS1 inhibitors for treating disease
-
Application No.: US17660541Application Date: 2022-04-25
-
Publication No.: US11958849B2Publication Date: 2024-04-16
- Inventor: Maria Emilia Di Francesco , Philip Jones , Timothy Heffernan , Matthew M. Hamilton , Zhijun Kang , Michael J. Soth , Jason P. Burke , Kang Le , Christopher Lawrence Carroll , Wylie S. Palmer , Richard Lewis , Timothy McAfoos , Barbara Czako , Gang Liu , Jay Theroff , Zachary Herrera , Anne Yau
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agent Cynthia Hathaway; Lauren L. Stevens; Erik M. Larsen
- The original application number of the division: US15624168 2017.06.15
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61K31/4192 ; A61K31/433 ; A61K31/4439 ; A61K31/444 ; A61K31/454 ; A61K31/497 ; A61K31/501 ; A61K45/06 ; C07D401/14 ; C07D403/06 ; C07D403/14 ; C07D405/14 ; C07D417/06 ; C07D493/08
Abstract:
Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I:
Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Public/Granted literature
- US20230124815A1 GLS1 INHIBITORS FOR TREATING DISEASE Public/Granted day:2023-04-20
Information query
